Pro/con clinical debate: Are steroids useful in the management of patients with septic shock?

Critical Care

Volumn 6, Issue 2, 2002, Pages 113-116

  Ritacca, Frank V ^a   Simone, Carmine ^b,c   Wax, Randy ^a,c   Craig, Katherine G ^d   Walley, Keith R ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CORTICOSTEROID; CORTICOTROPIN; FLUDROCORTISONE; HYDROCORTISONE; HYPERTENSIVE FACTOR; NORADRENALIN; PLACEBO; STEROID;

ADULT; BLEEDING; CASE REPORT; CONVALESCENCE; CORTICOTROPIN TEST; DRUG INFUSION; HEART FAILURE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; INFECTION; INTENSIVE CARE UNIT; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; NOTE; PRIORITY JOURNAL; SEPTIC SHOCK; STEROID THERAPY; URINE VOLUME;

EID: 0036219476     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc1467     Document Type: Note

References (22)

1. Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
2. Steroid controversy in sepsis and septic shock: A meta-analysis
3. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin
4. Glucocorticoid receptors
5. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
6. Beta-adrenergic receptors and their regulation
7. Reversal of late septic shock with supraphysiologic doses of hydrocortisone
8. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single center study
9. Effects of the combination of hydrocortisone (HC)-fludro-cortisone (FC) on mortality in septic shock
10. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors
11. Severe sepsis and septic shock: Definitions, epidemiology, and clinical manifestations
12. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized, double-blind, placebo-controlled trial
13. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome: A randomized, controlled, double-blind, multicenter clinical trial
14. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: A randomized, double-blind, placebo-controlled trial
15. Efficacy and safety of recombinant human activated protein C for severe sepsis
16. Corticosteroid therapy in severe illness
17. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: Altered response to corticotropin-releasing hormone
18. Beta-blocker therapy for heart failure: The evidence is in, now the work begins
19. Spectrum of cortisol and response to ACTH in ICU patients
20. Variable adrenocortical function in acute medical illness
21. Variations in adrenocortical responsiveness during severe bacterial infections
22. Corticosteroids in septic shock: Resurrection of the last rites